Sector Stock Trends: Steel Strength to Healthcare and Energy Storage

섹터 동향 | Fri Jul 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) | 7 sources

Steel sector strength confirmed by Cleveland-Cliffs surge, BioNTech and Pfizer oncology pipelines, and Eos Energy weakness highlight mixed sector performances.

Analysis

[Cleveland-Cliffs] surged on strong steel demand and pricing ^[3]

• Closed at $10.96
• up 15.98%
• Trading volume up 223% versus 3-month average
• Q2 adjusted EBITDA of $286M
• up sharply from Q1's $95M
• Q3 adjusted EBITDA guidance of $575M

[Nucor and Steel Dynamics] rallied alongside domestic steel sector strength ^[3]

• Nucor up 2.23% to $241.15
• Steel Dynamics up 0.81% to $240.57
• Steel Dynamics posted strong Q2 earnings and record shipments
• Nucor to report earnings next week

[BioNTech] pivoted business focus to oncology market post-COVID ^[2]

• Targeting $516.2B cancer therapeutics market by 2035
• Projected 9.3% CAGR
• Over 25 phase 2 and 3 oncology clinical trials underway
• Pumitamig
• co-developed with Bristol Myers Squibb
• shows promise

[Pfizer] offered 7% dividend yield alongside oncology pipeline restructuring ^[6]

• Cash dividend payout ratio of 107.7% confirms sustainability
• Padcev approved in combination with Keytruda for muscle-invasive bladder cancer
• 50% reduction in risk of death or recurrence
• Padcev could add over $1B to peak sales

[Eos Energy] hit 52-week low on production issues and earnings miss ^[4]

• Shares plunged 48.7% in first half of 2026
• Plunged 61% in February alone
• FY2025 net loss of $970M
• Established Frontier Power USA joint venture with Cerberus Capital
• Q1 backlog declined to $644.6M

[Planet Labs] saw director insider stock sale amid 323% rally ^[5]

• Director John W. Raymond sold 6
• 494 shares (approximately $169
• 883)
• Weighted average sale price of $26.16
• Trailing 12-month total return of 323%
• Market capitalization of $8.6B
• Transaction under pre-established 10b5-1 sale plan

[S&P 500 Options Market] highlighted August volatility risk amid posted gamma regime shift ^[7][1]

• 10-year Treasury yield touched 4.7%
• highest since January 2025
• S&P 500 less than 3% off all-time highs
• Gamma positioning concentrated near 7
• 500
• Large sell-off risk if SPY falls below 740
• Seasonal pattern of rising volatility from August through October

Sources

• [1] The stock market’s calm is cracking. Here’s how to prepare for an August shock. - MarketWatch Top Stories
• [2] BioNTech's Next Act Has Nothing to Do With COVID. Here's the $500 Billion Market Some Investors Are Ignoring - The Motley Fool
• [3] Stock Market Today, July 23: Cleveland-Cliffs Stock Soars on Robust Steel Demand and Pricing - The Motley Fool
• [4] Why Eos Energy Stock Just Hit a 52-Week Low After a 49% Plunge in the First Half of 2026 - The Motley Fool
• [5] A Planet Labs Director Sold Over 6,000 Shares Amid a 323% Stock Rally. What Does That Mean for Investors? - The Motley Fool
• [6] Is Pfizer's 7% Dividend Yield Too Good to Be True? Here's the Straight Answer - The Motley Fool
• [7] As the S&P 500 sells off, traders eye key 'risk pivot' level - CNBC Investing